Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
04/1995
Reliability:
1 (reliable without restriction)

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1995

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 401 (Acute Oral Toxicity)
GLP compliance:
yes
Test type:
standard acute method
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
Disodium phosphonate
EC Number:
237-249-1
EC Name:
Disodium phosphonate
Cas Number:
13708-85-5
Molecular formula:
Na2HPO3
IUPAC Name:
disodium phosphonate
Test material form:
solid: particulate/powder
Remarks:
migrated information: powder

Test animals

Species:
rat
Strain:
Wistar
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Zucht Winkelmann, Paderborn
- Age at study initiation: adult
- Weight at study initiation: 200 g (females), 220 g (males9
- Housing: single cages
- Water (e.g. ad libitum): ad libitum

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 °C ± 2 °C
- Humidity (%): 50 - 60 %
- Photoperiod (hrs dark / hrs light): 12/12

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
other: tylose
Details on oral exposure:
VEHICLE
- Concentration in vehicle: 20 - 30 %
- Amount of vehicle (if gavage): 1.0 - 1.7 ml/100 g bw
Doses:
2,000 mg/kg bw
3,000 mg/kg bw
4,000 mg/kg bw
5,000 mg/kg bw
No. of animals per sex per dose:
3
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: 24 h, 7 d, 14 d
- Necropsy of survivors performed: yes
- Other examinations performed: macroscopic histopathology

Results and discussion

Effect levels
Sex:
male/female
Dose descriptor:
LD50
Effect level:
4 000 mg/kg bw
Based on:
test mat.
Mortality:
2,000 mg/kg bw (0/6)
3,000 mg/kg bw (0/6)
4,000 mg/kg bw (2/6)
5,000 mg/kg bw (6/6)
Clinical signs:
other: 4,000 mg/kg bw: delayed reactivity
Gross pathology:
no effects related to the substance
Other findings:
- Organ weights: normal
- Histopathology: no findings

Applicant's summary and conclusion

Interpretation of results:
practically nontoxic
Remarks:
Migrated information Criteria used for interpretation of results: other: FDA 1959, OECD 401 (1981)
Conclusions:
The LD50 was deteremined to be 4,000 mg/kg bw; therefore the substance can be considered as practically non-toxic.
Executive summary:

The LD50 was deteremined to be 4,000 mg/kg bw; therefore the substance can be considered as practically non-toxic.